Work

Maximum severity score (MSS) of baseline patient-reported Lung Cancer Symptom Scale (LCSS) as a prognostic and predictive factor for overall survival (OS) in the Phase III SQUIRE study.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.8099

Authors: Martin Reck, Richard J. Gralla, Philip Bonomi, Mark A. Socinski, Victoria Soldatenkova, Javad Shahidi, Patrick Peterson, Jacqueline Brown, Coleman K. Obasaju, Nick Thatcher

Institutions: German Center for Lung Research, LungenClinic Grosshansdorf, Albert Einstein College of Medicine, Jacobi Medical Center, Rush University Medical Center, University of Pittsburgh, Eli Lilly (Germany), Eli Lilly (United States), Eli Lilly (United Kingdom), The Christie Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2598436879

Cites:

Cited by: 2

Related to: 10